Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · October 23, 2018

Dorzolamide–Timolol as Adjuvant Therapy in Neovascular AMD Refractory to Anti-VEGF Treatment

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
Efficacy of Adjuvant Topical Dorzolamide-Timolol in Patients With Neovascular Age-Related Macular Degeneration Refractory To Anti-Vascular Endothelial Growth Factor Therapy
Retina (Philadelphia, Pa.) 2018 Aug 29;[EPub Ahead of Print], JH Lee, SC Lee, SH Byeon, HJ Koh, SS Kim, CS Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading